Re-understand the clinical significance of natriuretic peptide family
10.3760/cma.j.issn.1009-9158.2017.06.002
- VernacularTitle:重新认识利钠肽家族的临床意义
- Author:
Zhenlu ZHANG
- Keywords:
Heart failure;
Natriuretic peptide,brain;
Peptide fragments;
Neprilysin;
Angiotensin receptor antagonists
- From:
Chinese Journal of Laboratory Medicine
2017;40(6):414-416
- CountryChina
- Language:Chinese
-
Abstract:
Although BNP/NT-proBNP has been widely accepted as the gold standard biomarker for the diagnosis and prognosis of heart failure, and current guidelines on heart failure list the application of natriuretic peptide in the diagnosis and prognosis of heart failure as ⅠA recommendations, the latest studies discovered a lot of new finding, which show that some of our thoughts on the test result of BNP/NT-proBNP is wrong. It is important for clinical and laboratory physicians to understand the latest progress on natriuretic peptide family. It will help them use BNP/NT-proBNP more properly. In the future, as the new drugs, which work via natriuretic peptide family, will be used widely in patients, the test of natriuretic peptide family will become more important.
